Cencoravs.McKesson
COR vs MCK · both in Distribution & pharmacy infrastructure, part of the Medicine, pharma & life science value chain: Wholesalers, distribution and pharmacy chains that get medicines to patients.
McKesson is about 1.6× larger than Cencora by market cap; McKesson trades at the lower P/E (19.8 vs 23.2); year to date, McKesson leads (−1.7% vs −10.2%).
Side by side
| COR | MCK | |
|---|---|---|
| Market cap | $59.2B | $94.4B |
| Price | $303.44 | $805.96 |
| Today | +0.3% | +1.7% |
| Return YTD | −10.2% | −1.7% |
| Return 1Y | +2.1% | +12.8% |
| P/E | 23.2 | 19.8 |
| P/S | 0.2 | 0.2 |
| P/B | 17.4 | 16.0 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
CencoraCOR
American pharmaceutical wholesaler (formerly AmerisourceBergen) — distributes medicines and specialty drugs to the healthcare sector.
Full COR profile →McKessonMCK
American pharmaceutical wholesaler — one of the largest distributors of medicines to pharmacies, hospitals and clinics in the US.
Full MCK profile →More comparisons in Distribution & pharmacy infrastructure
See where COR and MCK sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →